BridgeBio Pharma, Inc. (BBIO) Q3 2025 Earnings Name October 29, 2025 4:30 PM EDT
Firm Members
Chinmay Shukla
Neil Kumar – Co-Founder, CEO & Director
Matthew Outten – Chief Business Officer
Thomas Trimarchi – CFO & President
Convention Name Members
Salim Syed – Mizuho Securities USA LLC, Analysis Division
Tyler Van Buren – TD Cowen, Analysis Division
Biren Amin – Piper Sandler & Co., Analysis Division
Joshua Schimmer – Cantor Fitzgerald & Co., Analysis Division
Cory Kasimov – Evercore ISI Institutional Equities, Analysis Division
Anupam Rama – JPMorgan Chase & Co, Analysis Division
Lin Tsai – Jefferies LLC, Analysis Division
Danielle Brill Bongero – Truist Securities, Inc., Analysis Division
Jason Zemansky – BofA Securities, Analysis Division
Kyuwon Choi – Goldman Sachs Group, Inc., Analysis Division
Trevor Allred – Oppenheimer & Co. Inc., Analysis Division
Presentation
Operator
Good afternoon. I will likely be your convention operator immediately. [Operator Instructions] Earlier than we start, I wish to remind everybody that immediately’s name could include forward-looking statements inside the that means of the federal securities legal guidelines, together with, however not restricted to, statements about BridgeBio’s future working and monetary efficiency, enterprise plans and prospects and technique.
These statements are primarily based on present expectations and assumptions which might be topic to dangers and uncertainties, which may trigger precise outcomes to vary materially from these expressed or implied in these forward-looking statements. For a dialogue of those dangers and uncertainties, please discuss with the disclosure in immediately’s earnings launch and BridgeBio’s periodic stories and SEC filings. All statements made listed below are primarily based on data accessible to BridgeBio as of immediately, and the corporate undertakes no obligation to replace any forward-looking statements made throughout this name, besides as required by regulation. With that accomplished, BridgeBio, chances are you’ll start your convention.
Chinmay Shukla
Good afternoon, everybody, and thanks for becoming a member of BridgeBio Pharma’s Third Quarter 2025 Earnings Name. I am Chinmay Shukla, Senior Vice President of
